Call for Papers | JNCI Cancer Spectrum
JNCI Cancer Spectrum is a peer-reviewed, open-access journal that publishes 6 issues per year online. The journal publishes manuscripts that describe new findings of particular significance across a full range of clinical and translational cancer research, including prevention, screening, and treatment, as well as clinically relevant epidemiologic, public health, and policy research.
In addition to novel results, the journal will also consider studies with meaningful confirmatory or negative findings, and it encourages systematic reviews, meta-analyses, and expert reviews of important topics. The journal also invites scholarly manuscripts discussing emerging hypotheses and research priorities. The journal employs a process of rigorous yet rapid review of submitted manuscripts so that findings of high scientific and medical interest can be published with minimum delay.
Call for Papers: Exercise and Nutrition
JNCI Cancer Spectrum is calling for papers investigating how exercise and nutrition impact cancer outcomes. We particularly encourage studies that involve clinical trials or prospective data collection over papers that are exploratory and analyze existing data for statistical associations without a well-considered biological mechanism. All manuscript types will be considered. Accepted papers will be published normally on advance access and moved into the open issue but also housed in a special collection on the journal website.
Editors: Justin Brown and Leila Tchelebi
Deadline for submissions: September 1, 2025
Why publish your research with JNCI Cancer Spectrum?
Authors who publish with JNCI Cancer Spectrum will benefit from:
- Open access publication: All JNCI Cancer Spectrum articles are published under an open access license meaning your research will be free to read and access globally. Open access publication increases the visibility of your research and creates more opportunities for fellow researchers to read, share, cite, and build upon your findings.
- Impact: JNCI Cancer Spectrum recently received its inaugural Impact Factor of 3.4 (Clarivate, 2023) and boasts a CiteScore of 7.7 (Scopus, 2023).
- A commitment to diversity, equity, and inclusion (DEI): JNCI Cancer Spectrum welcomes and encourages submissions from authors of all backgrounds, will actively recruit reviewers and editorial board members from diverse backgrounds, and will continue to foster bias-free peer review.
Explore more benefits of publishing with us.
When submitting your research, please indicate your interest in the relevant call for papers by answering the corresponding prompt on Editorial Manager.
